Erlonat 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Erlonat 150 mg Tablet

Erlonat 150 mg Tablet

Erlonat 150 mg Tablet contains erlotinib 150 mg, a targeted anticancer medicine that inhibits epidermal growth factor receptor (EGFR) signaling. It is used mainly for non-small cell lung cancer and pancreatic cancer. The tablet is taken orally on an empty stomach as prescribed by a qualified healthcare professional.

BUY NOW

Category

Erlotinib works by blocking EGFR tyrosine kinase activity, which can slow the growth and spread of certain cancer cells. It is prescribed according to the cancer type, molecular characteristics, and treatment plan determined by the oncologist. Treatment may require monitoring for rash, diarrhea, liver-related effects, and other adverse reactions. Erlotinib should be taken exactly as directed because food can affect its absorption.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer / Marketer Natco Pharma Ltd

Product Also Known As

Erlonat 150 mg Tablet, Erlonat 150mg Tablet, Erlonat 150 Tablet, Erlotinib 150 mg Tablet, Erlotinib 150mg Tablet, Erlotinib Hydrochloride 150 mg Tablet, Erlotinib Anticancer Tablet